Lung cancer treatment with targeted therapy

Targeted therapy is a type of specific treatment that targets specific molecules or proteins within cancer cells. Blocking them can help stop or slow lung cancer's progression. Targeted therapies may be used separately or combined with other cancer treatments, such as chemo or radiation therapy. Therapies, including monoclonal antibodies and proteins, are designed to target specific molecules in cancer cells. They can help the immune system recognize and attack malignant cells. In addition, small molecules called inhibitors can stop some proteins or enzymes that help cancer cells grow. Some therapies are taken as pills, while others are given through an intravenous (IV) line. The targeted therapy may depend on the type of lung cancer and overall health. The effectiveness of targeted therapy varies depending on the specific type of treatment and the tumor stage. For example, targeted therapies may be more effective in treating certain types of lung cancer, such as non-small cell lung cancer (NSCLC), with specific genetic mutations. Targeted therapies may shrink tumors in the lung or slow cancer's progression. However, it is unsuitable for all lung cancer types, and cancer may eventually progress despite treatment. Targeted treatments are well tolerated and may have fewer side effects than chemotherapy. However, they cause fatigue, diarrhea, rash, and nausea.